The Road towards Triple Agonists: Glucagon-Like Peptide 1, Glucose-Dependent Insulinotropic Polypeptide and Glucagon Receptor - An Update

Agnieszka Jakubowska, Carel Wynand le Roux, Adie Viljoen
ISSN / E-ISSN
— / —
DOI
10.3803/enm.2024.1942 ↗
Volume · Issue · Pages
39 · 1 · 12-22
Publisher
Korean Endocrine Society
Article URL
https://doi.org/10.3803/enm.2024.1942 ↗
Article details
Unverified
Publication date (each date has its type and source)
15 Feb 2024
OpenAlex publication date · source: OpenAlex
Dates on record for this article
TypeDateSource
OpenAlex publication date15 Feb 2024 OpenAlex

Keywords (as given): GLP-1 receptor agonists; glucose-dependent insulinotropic polypeptide; glucagon receptor agonist; retatrutide; obesity; type 2 diabetes; weight loss; cardiometabolic benefits; hepatic steatosis; gastrointestinal hormones

HEC Status at Publication Not the journal's current status

HEC Status at PublicationConclusive
HEC status at publication Recognized X
Based on the recorded HEC dataset applicable to the article's publication date. Listed as X in the HEC list for 2023–24.
Journal
Endocrinology and Metabolism
Publication date used
15 Feb 2024 (OpenAlex publication date)
Applicable HEC period
2023–24 (version 1) · 01 Jul 2023 – 30 Sep 2024
Category
X
Recognition status
Recognized (OK_RECORD_FOUND)
Source
HJRS 2023-24 page 1240, row 8706
Verification status
Verified against source · last verified 23 Sep 2026
This is an automatically generated summary based on the information available on the publication date. Terms & conditions apply.